Chief Business Officer · ENANTA PHARMACEUTICALS INC · ENANTA PHARMACEUTICALS INC — Stock Option (right to buy)
Side
A
Value
—
Shares
90.0K
Price
—
Executed
Nov 25, 2025
Disclosed
Nov 26, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 25 executedNov 26, 2025 disclosed
ENTA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
ENANTA PHARMACEUTICALS INC — Stock Option (right to buy)
Ticker
ENTA
Shares
90.0K
Price per share
$0
Execution date (reported)
Nov 25, 2025
Owned after transaction
90.0K shares
Days from execution to publication
1
What this establishes
Luu Brendan filed this Form 4 reporting a grant or award of ENTA on Nov 25, 2025. It became public on Nov 26, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Luu Brendancik:0001842369
Issuer
ENANTA PHARMACEUTICALS INCcik:0001177648
Revision history · 0
No field has changed since this record was first ingested.
